This comprehensive evaluation allowed analysis of which CSF tau measures are most strongly associated with amyloid plaques and neurofibrillary tangles as measured by PET, regional brain volumes, clinical status (cognitively unimpaired or impaired) and dementia severity. This evidence concerns the gene MAPT and dementia.